IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Corriente Advisors, LLC

Q2 2020 Holdings

Filed 2020-08-14 | 16 holdings | $8.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$6.0M460,00068.6%
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$1.7M40,00019.8%
Cardiff Oncology Inc(CRDF)COM14147L108$869.0K173,36110.0%
Maxar Technologies Inc(MAXREUR)COM57778K105$34.1K1,900,0000.4%
Reata Pharmaceuticals Inc(RETAEUR)CL A75615P103$23.0K147,5000.3%
Sonos Inc(SONO)COM83570H108$23.0K1,570,0000.3%
Aptose Biosciences IncCOM NEW03835T200$17.5K2,771,3120.2%
CUE Biopharma Inc(CUE)COM22978P106$16.2K659,9870.2%
Replimune Group Inc(REPL)COM76029N106$12.1K485,0000.1%
Uniqure NV(QURE)SHSN90064101$8.1K180,0000.1%
Ocular Therapeutix Inc(OCUL)COM67576A100$6.0K720,0000.1%
Tesla Inc(TSLA)COM88160R101$2.2K2,0000.0%
Diamedica Therapeutics Inc(DMAC)COM NEW25253X207$1.4K201,2480.0%
PAN Amern Silver Corp(PAAS)COM697900108$91230,0000.0%
Pieris Pharmaceuticals IncCOM720795103$837270,0000.0%
Redwood TR Inc(RWT)COM758075402$52575,0000.0%